Table 2.
Clearance of serum HBV markers in Group BC and Group B
| Group BC (n = 40, %) | Group B (n = 16, %) | |
| HBsAg clearance | ||
| Until 1994 | 6 (15%) | 0 (0%) |
| Until 2002 | 27 (67.5%) | 8 (50%) |
| HBeAg clearance/seroconversion | ||
| HBeAg clearance | ||
| Until 1994 | 29 (72.5%) | 10 (62.5%) |
| Until 2002 | 37 (92.5%) | 14 (87.5%) |
| HBeAg seroconversion | 22 (55.5%) | 12 (75%) |
| HBV DNA clearance | ||
| Until 1994 | 3 (7.5%) | 2 (12.5%) |
| Until 2002 | 35 (87.5%) | 13 (81.2%) |
| HBV clearance | 27 (67.5%) | 7 (43.8%) |
| Male | 18 (85.7%)a | 4 (66.7%) |
| Female | 9 (47.4%)b | 3 (30%) |
| Low HBV DNA level group (< 105 copies/mL) | 17 (70.8%) | 4 (57.1%) |
| High HBV DNA level group (≥ 105 copies/mL) | 10 (62.5%) | 3 (33.3%) |
Note.
a
vs.
b
χ2 = 6.686, P = 0.010.